These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2511618)

  • 21. Transplanting tissue into the brain for function: use in a model of Parkinson's disease.
    Wyatt RJ; Morihisa JM; Nakamura RK; Freed WJ
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():199-208. PubMed ID: 3726282
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroprotection for Parkinson's disease: prospects and promises.
    Olanow CW; Schapira AH; Agid Y
    Ann Neurol; 2003; 53 Suppl 3():S1-2. PubMed ID: 12666093
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on the management of Parkinson's disease.
    Standaert DG; Stern MB
    Med Clin North Am; 1993 Jan; 77(1):169-83. PubMed ID: 8093493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate Parkinson's disease. Strategies for maximizing treatment.
    Silverstein PM
    Postgrad Med; 1996 Jan; 99(1):52-4, 61-3, 67-8, passim. PubMed ID: 8539210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical inquiries. What is the best initial treatment of Parkinson's disease?
    Schreck J; Kelsberg G; Rich J; Ward R
    J Fam Pract; 2003 Nov; 52(11):897-9. PubMed ID: 14599387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current diagnosis and treatment of Parkinson's disease].
    Kuno S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):104-6. PubMed ID: 10377828
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 28. Practical importance of neuroprotection in Parkinson's disease.
    Riederer P; Gille G; Müller T; Przuntek H; Reichmann H; Riess O; Schwartz A; Schwarz J; Vogt T
    J Neurol; 2002 Oct; 249 Suppl 3():III/53-6. PubMed ID: 12522574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intracaudate grafting of the adrenal medulla in the treatment of Parkinson's disease].
    Zhang WC; Ding MC; Jiao SS
    Zhonghua Wai Ke Za Zhi; 1988 Jan; 26(1):1-5, 59. PubMed ID: 3197528
    [No Abstract]   [Full Text] [Related]  

  • 31. Tissue transplantation for Parkinson's disease.
    Calne DB; McGeer PL
    Can J Neurol Sci; 1988 Nov; 15(4):364-5. PubMed ID: 3208220
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cerebral implants in Parkinson's disease].
    Obeso JA; Luquin MR; Vaamonde J; Herrero T; Guridi J; Martínez-Lage JM
    Neurologia; 1989 Oct; 4(8):302-3. PubMed ID: 2641998
    [No Abstract]   [Full Text] [Related]  

  • 33. Selegiline and mortality in Parkinson's disease.
    Olanow CW; Fahn S; Langston JW; Godbold J
    Ann Neurol; 1996 Dec; 40(6):841-5. PubMed ID: 9007088
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation in Parkinson's disease.
    Lees AJ
    Br J Hosp Med; 1989 Oct; 42(4):261, 263. PubMed ID: 2804500
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intracerebral grafts in Parkinson's disease, a great bustle].
    Degos JD
    Rev Prat; 1989 Jan; 39(1):43-4. PubMed ID: 2645640
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroprotective therapy for Parkinson's disease.
    Koller WC
    Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of Parkinson's disease: a possibility of oxidation].
    Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Cabrera-Valdivia F
    Neurologia; 1993 Apr; 8(4):138-46. PubMed ID: 8517962
    [No Abstract]   [Full Text] [Related]  

  • 38. MAO-B inhibitors for the treatment of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S38-44. PubMed ID: 12211138
    [No Abstract]   [Full Text] [Related]  

  • 39. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 40. Antioxidative therapeutic strategies for Parkinson's disease.
    Shoulson I
    Ann N Y Acad Sci; 1992 May; 648():37-41. PubMed ID: 1637072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.